Study examines safety and effectiveness of infliximab biosimilar in patients with inflammatory bowel disease
Biosimilars are biologic agents that highly similar to original biomedical medications (originators), but are much cheaper. A new study in Alimentary Pharmacology & Therapeutics found no differences in drug levels and disease ...
Dec 6, 2017
0
0